"Sacituzumab govitecan 2021 trial: A total of
Saturday, March 29, 2025 08:50:13 AM
Post# of 151353
Post# of 151353
(Total Views: 395)
Posted On: 03/20/2025 6:54:40 PM
"Sacituzumab govitecan 2021 trial:
A total of 468 patients without brain metastases were randomly assigned to receive sacituzumab govitecan (235 patients) or chemotherapy (233 patients)"
The #1 approved drug today:
Excluded brain in approval trial.
Ladies of Leronlimab include brain metastases @ cancer-free??
Elusive wholy grail for humanity.
And this too from Monday news:
" The exciting survival outcomes announced in February 2025 provide early clinical evidence of leronlimab’s potential impact across the field of solid-tumor oncology."
My bet:
mTNBC has brain cancer-free --- explaining Dr. J's excitement to publish results
A total of 468 patients without brain metastases were randomly assigned to receive sacituzumab govitecan (235 patients) or chemotherapy (233 patients)"
The #1 approved drug today:
Excluded brain in approval trial.
Ladies of Leronlimab include brain metastases @ cancer-free??
Elusive wholy grail for humanity.
And this too from Monday news:
" The exciting survival outcomes announced in February 2025 provide early clinical evidence of leronlimab’s potential impact across the field of solid-tumor oncology."
My bet:
mTNBC has brain cancer-free --- explaining Dr. J's excitement to publish results
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼